Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A McCullough

Showing results (71-80 of 855) with videos related to

Pageof 86
Sort By:
European Journal of Heart Failure|November 29, 2019
Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shockBharath Raju, Peter A McCullough
Advances in Chronic Kidney Disease|October 13, 2018
Cardiorenal Syndrome: A Call to Action for a Pressing Medical IssuePeter A McCullough, Sandeep Soman
Annals of Translational Medicine|November 9, 2019
The Promise of next generation sequencing micro RNA for the discovery of new targets in contrast induced acute kidney injuryAyman Haq, Peter A McCullough
The Lancet. Global Health|April 23, 2016
Chronic kidney disease from screening, detection, and awareness, to preventionMelody Sherwood, Peter A McCullough
BMC Medical Imaging|May 26, 2011
Patient discomfort associated with the use of intra-arterial iodinated contrast media: a meta-analysis of comparative randomized controlled trialsPeter A McCullough, Patrizio Capasso
Advances in Chronic Kidney Disease|July 9, 2004
Optimal dialysis for the end-stage renal disease patient with cardiovascular diseaseFrancis Dumler, Peter A McCullough
Nephron. Clinical Practice|October 25, 2014
Statins for the prevention of contrast-induced acute kidney injuryTimothy Ball, Peter A McCullough
Nephron|December 6, 2017
Real or Perceived: Hyperkalemia Is a Major Deterrent for Renin-Angiotensin Aldosterone System Inhibition in Heart FailurePeter A McCullough, Janani Rangaswami
JACC. Heart Failure|March 3, 2018
Efficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the DetailsJanani Rangaswami, Peter A McCullough
Journal of the American College of Cardiology|September 3, 2013
Ascorbic acid for the prevention of contrast-induced acute kidney injuryPeter A McCullough, Krittapoom Akrawinthawong
Pageof 86

Showing results (71-80 of 855) with videos related to

Sort By:
Pageof 86
European Journal of Heart Failure|November 29, 2019
Circulating plasma dipeptidyl dipeptidase 3 and the prognosis of cardiogenic shockBharath Raju, Peter A McCullough
Advances in Chronic Kidney Disease|October 13, 2018
Cardiorenal Syndrome: A Call to Action for a Pressing Medical IssuePeter A McCullough, Sandeep Soman
Annals of Translational Medicine|November 9, 2019
The Promise of next generation sequencing micro RNA for the discovery of new targets in contrast induced acute kidney injuryAyman Haq, Peter A McCullough
The Lancet. Global Health|April 23, 2016
Chronic kidney disease from screening, detection, and awareness, to preventionMelody Sherwood, Peter A McCullough
BMC Medical Imaging|May 26, 2011
Patient discomfort associated with the use of intra-arterial iodinated contrast media: a meta-analysis of comparative randomized controlled trialsPeter A McCullough, Patrizio Capasso
Advances in Chronic Kidney Disease|July 9, 2004
Optimal dialysis for the end-stage renal disease patient with cardiovascular diseaseFrancis Dumler, Peter A McCullough
Nephron. Clinical Practice|October 25, 2014
Statins for the prevention of contrast-induced acute kidney injuryTimothy Ball, Peter A McCullough
Nephron|December 6, 2017
Real or Perceived: Hyperkalemia Is a Major Deterrent for Renin-Angiotensin Aldosterone System Inhibition in Heart FailurePeter A McCullough, Janani Rangaswami
JACC. Heart Failure|March 3, 2018
Efficacy of Subcutaneous Versus Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the DetailsJanani Rangaswami, Peter A McCullough
Journal of the American College of Cardiology|September 3, 2013
Ascorbic acid for the prevention of contrast-induced acute kidney injuryPeter A McCullough, Krittapoom Akrawinthawong
Pageof 86